XML 50 R38.htm IDEA: XBRL DOCUMENT v3.25.3

OPTIONS AND AWARDS (Tables)

9 Months Ended

Sep. 30, 2025

Share-Based Payment Arrangement [Abstract]

Schedule of Assumptions for Stock Options Granted

The Company used the following assumptions for stock options granted during the three months ended September 30, 2025 and 2024:

Grant Year						Options Granted						Weighted Average Risk-Free Rate						Expected Life						Weighted Average Volatility												Weighted Average Dividend Yield
2025						190						4.0%						6.2 years						39.1%												0.2%
2024						112						3.8%						6.2 years						40.3%												0.2%

The Company used the following assumptions for stock options granted during the nine months ended September 30, 2025 and 2024:

Grant Year						Options Granted						Weighted Average Risk-Free Rate						Expected Life						Weighted Average Volatility						Weighted Average Dividend Yield
2025						517						4.1%						6.2 years						39.3%						0.2%
2024						466						4.2%						6.1 years						40.7%						0.2%

Schedule of Exercise Price and Fair Value Displayed at Grant Date for Stock Option Grants

For the nine months ended September 30, 2025 and 2024, the following represents the exercise price and fair value displayed at grant date for stock option grants:

Grant Year						Granted						Weighted Average Exercise Price						Weighted Average Fair Value of Options
2025						517						$	149.08					$	66.56
2024						466						$	127.07					$	57.81

Schedule of Employee Stock Option Roll Forward

The following table represents the employee stock option activity during the nine months ended September 30, 2025:

			Number of Options Outstanding						Weighted Average Exercise Price						Number of Options Vested						Weighted Average Exercise Price of Options Vested
January 1, 2025			3,987						$	78.84					1,895						$	52.64
Granted			517						149.08
Forfeited			(46)						107.63
Exercised			(455)						49.93
September 30, 2025			4,003						$	90.87					1,928						$	62.74

Schedule of Aggregate Intrinsic Value of Options

The aggregate intrinsic value of options outstanding, vested, expected to vest and exercised as of September 30, 2025 and December 31, 2024 is as follows:

Options						September 30, 2025						December 31, 2024
Outstanding						$	327,883					$	219,309
Vested						212,109						152,011
Expected to vest						108,579						63,243

Schedule of Nonvested Restricted Stock Awards

A summary of the status of the Company's non-vested restricted stock awards as of September 30, 2025 and changes during the nine months ended September 30, 2025 is presented below:

			Non-Vested Restricted Awards						Weighted Average Grant Date Fair Value
Nonvested at January 1, 2025			435						$	102.71
Granted			177						141.85
Vested			(195)						104.05
Forfeited			(9)						107.92
Nonvested at September 30, 2025			408						$	119.62

Schedule of Stock-Based Compensation Expense

Stock-based compensation expense recognized for the Company's equity incentive plans and long-term incentive plan for the three and nine months ended September 30, 2025 and 2024 was as follows:

			Three Months Ended September 30,												Nine Months Ended September 30,
			2025						2024						2025						2024
Stock-based compensation expense related to stock options			$	8,361					$	5,699					$	22,568					$	16,205
Stock-based compensation expense related to restricted stock awards			3,999						2,883						11,162						8,546
Stock-based compensation expense related to restricted stock awards to non-employee directors			508						595						1,457						1,635
TOTAL			$	12,868					$	9,177					$	35,187					$	26,386

X

- References

No definition available.

+ Details

Name:	us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the change in common stock outstanding.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the changes in outstanding nonvested restricted stock units.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Subparagraph (f)(2)
-Name Accounting Standards Codification
-Paragraph 2
-Section 50
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the weighted-average grant-date fair value of equity options or other equity instruments granted during the year.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for exercisable or convertible options that are fully vested and expected to vest. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Subparagraph (e)(2)
-Name Accounting Standards Codification
-Paragraph 2
-Section 50
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration